Hospital Value-Based Purchasing (VBP) Program Patient Safety Series: MRSA/CDI — 1 C.E.
Tuesday, April 26, 2016 Archived
2 p.m. ET
Provide hospitals with an understanding of Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (CDI) rates within the Hospital VBP Program from hospitals who have improved their rates by implementing Healthcare-Associated Infection (HAI) prevention processes.
Michael S. Calderwood, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Assistant Hospital Epidemiologist/Associate Director of Antimicrobial Stewardship
Brigham and Women’s Hospital
Neil A. Zaboy RN, BSN, CIC
Director Infection Prevention
Western Arizona Regional Medical Center